C

Cannara Biotech Inc
XTSX:LOVE

Watchlist Manager
Cannara Biotech Inc
XTSX:LOVE
Watchlist
Price: 1.7 CAD 0.59% Market Closed
Market Cap: 161.3m CAD

Cannara Biotech Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Cannara Biotech Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
Cannara Biotech Inc
XTSX:LOVE
Revenue
CA$107.3m
CAGR 3-Years
44%
CAGR 5-Years
111%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Revenue
$10B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
0%
Canopy Growth Corp
TSX:WEED
Revenue
CA$278.6m
CAGR 3-Years
-16%
CAGR 5-Years
-10%
CAGR 10-Years
52%
Sundial Growers Inc
NASDAQ:SNDL
Revenue
CA$951.6m
CAGR 3-Years
24%
CAGR 5-Years
73%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Revenue
$132.4m
CAGR 3-Years
12%
CAGR 5-Years
29%
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Revenue
CA$413.8m
CAGR 3-Years
15%
CAGR 5-Years
18%
CAGR 10-Years
87%
No Stocks Found

Cannara Biotech Inc
Glance View

Market Cap
155.4m CAD
Industry
Pharmaceuticals

Cannara Biotech, Inc. is a pharmaceutical company, which operates cannabis biotech facility. The company is headquartered in Montreal, Quebec. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. Its segments include Indoor cannabis operations and Real estate operations. The Indoor cannabis operations segment includes the cultivation, processing and sale of dried cannabis and cannabis derivatives exclusively for the Quebec and Canadian market. The Real estate operations segment is related to the Farnham building. The Company, through ShopCBD.com Inc., operates an online e-commerce platform in the United States hemp-based Cannabidiol (CBD) market. The firm sells dried cannabis products to provincial retail distributors and other licensed producers across Canada through Cannara Biotech (Quebec) Inc. The company owns approximately two cultivation facilities based in Quebec spanning over 1,650,000 square feet.

LOVE Intrinsic Value
2.72 CAD
Undervaluation 38%
Intrinsic Value
Price
C

See Also

What is Cannara Biotech Inc's Revenue?
Revenue
107.3m CAD

Based on the financial report for Aug 31, 2025, Cannara Biotech Inc's Revenue amounts to 107.3m CAD.

What is Cannara Biotech Inc's Revenue growth rate?
Revenue CAGR 5Y
111%

Over the last year, the Revenue growth was 31%. The average annual Revenue growth rates for Cannara Biotech Inc have been 44% over the past three years , 111% over the past five years .

Back to Top